Total Payments
$4,423
2024 Payments
$2,248
Companies
32
Transactions
167
Medicare Patients
712
Medicare Billing
$64,526
Payment Breakdown by Category
Food & Beverage$4,416 (99.8%)
Education$7.09 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,416 | 166 | 99.8% |
| Education | $7.09 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,057 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $758.16 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $345.00 | 17 | $0 (2024) |
| Boston Scientific Corporation | $232.18 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $229.24 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $175.01 | 9 | $0 (2024) |
| Amgen Inc. | $168.72 | 8 | $0 (2024) |
| Abbott Laboratories | $167.46 | 8 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $143.76 | 2 | $0 (2020) |
| Lilly USA, LLC | $115.11 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,248 | 83 | AstraZeneca Pharmaceuticals LP ($645.07) |
| 2023 | $1,462 | 57 | AbbVie Inc. ($351.81) |
| 2022 | $569.43 | 25 | ABBVIE INC. ($179.80) |
| 2020 | $12.42 | 1 | Merck Sharp & Dohme Corporation ($12.42) |
| 2019 | $131.34 | 1 | Merck Sharp & Dohme Corporation ($131.34) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Biological | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Biological | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.44 | General |
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: PAIN | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardio-renal | ||||||
| 08/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: PAIN | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $98.82 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 481 | 662 | $202,402 | $47,891 |
| 2022 | 6 | 231 | 272 | $87,364 | $16,635 |
Total Patients
712
Total Services
934
Medicare Billing
$64,526
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 292 | $108,624 | $22,378 | 20.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 78 | 83 | $44,322 | $11,777 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $22,184 | $6,604 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 57 | $13,965 | $3,584 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,808 | $1,380 | 17.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $2,915 | $955.80 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $950.00 | $574.56 | 60.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 37 | $333.00 | $310.80 | 93.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 19 | $779.00 | $163.50 | 21.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 13 | $390.00 | $123.76 | 31.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $132.00 | $40.92 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 149 | $57,216 | $9,918 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 45 | $12,285 | $2,327 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $9,126 | $2,250 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $7,448 | $1,723 | 23.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 20 | 20 | $1,100 | $354.80 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 21 | $189.00 | $61.74 | 32.7% |
About Dr. Caleb Dunlap, MD
Dr. Caleb Dunlap, MD is a Family Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1104386473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caleb Dunlap, MD has received a total of $4,423 in payments from pharmaceutical and medical device companies, with $2,248 received in 2024. These payments were reported across 167 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,416).
As a Medicare-enrolled provider, Dunlap has provided services to 712 Medicare beneficiaries, totaling 934 services with total Medicare billing of $64,526. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Jacksonville, FL
- Active Since 03/22/2019
- Last Updated 01/24/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104386473
Products in Payments
- VRAYLAR (Drug) $762.06
- Kerendia (Drug) $345.00
- AIRSUPRA (Drug) $311.55
- Veozah (Drug) $229.24
- FARXIGA (Drug) $208.72
- TRELEGY ELLIPTA (Drug) $175.01
- UBRELVY (Drug) $159.12
- EVENITY (Biological) $151.57
- NEXPLANON (Drug) $143.76
- QULIPTA (Drug) $135.71
- WATCHMAN Access System (Device) $124.90
- mild Device Kit (Device) $105.31
- Venovo (Device) $100.00
- QUVIVIQ (Drug) $90.35
- REXULTI (Drug) $85.33
- NURTEC ODT (Drug) $76.40
- PAINTEQ (Device) $74.08
- Rybelsus (Drug) $68.61
- MOUNJARO (Drug) $68.16
- INTELLIS ADAPTIVESTIM (Device) $66.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jacksonville
Colin Lacroix, M.d, M.D
Family Medicine — Payments: $94,208
Family Medicine $94,208
Dr. Sarfaraz Dhanji, Md, MD
Family Medicine — Payments: $48,705
Family Medicine $48,705
Dr. Kim Barbel-Johnson, D.o, D.O
Family Medicine — Payments: $46,143
Family Medicine $46,143
Victor Micolucci, M.d, M.D
Family Medicine — Payments: $39,554
Family Medicine $39,554
Herman Downey, Md, MD
Family Medicine — Payments: $32,440
Family Medicine $32,440
William Schwartz, D.o, D.O
Family Medicine — Payments: $32,173
Family Medicine $32,173